pre-IPO PHARMA

COMPANY OVERVIEW

Bloom Science is developing transformational medicines that target diseases in neurology and oncology. Our discovery platform starts with positive clinical outcomes that elucidates novel connections between these clinical outcomes, the microbiome, and critical disease pathways to accelerate drug discovery and deliver meaningful solutions to patients in the timely manner.


LOCATION

  • San Diego, CA, USA

  • THERAPEUTIC AREAS

  • Neurological DIsorders
  • Oncology

  • WEBSITE

    https://bloomscience.co


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Aug 17, 2023

    Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial of BL-001, a Potential First-in-Class Therapeutic Being Developed for Both Dravet Syndrome and ALS


    May 17, 2023

    Bloom Science Names Top Biotechnology Executive, Dr. Grace E. Colón, Board Chair


    Apr 25, 2023

    Bloom Science Completes Enrollment in Phase 1 Trial of BL-001, a First-in-Class Therapy Being Developed for Dravet Syndrome


    Dec 10, 2021

    Bloom Science recauda USD 12 millones en financiamiento de serie A USA - español USA - English


    Dec 9, 2021

    Bloom Science Raises USD $12 Million in Series A Financing


    For More Press Releases


    Google Analytics Alternative